INNOVATE BIOPHARMACEUTICALS, INC. (INNT) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 43 transactions totaling $624.2K, demonstrating a bullish sentiment with $624.2K in net insider flow. The most recent transaction on Jun 28, 2019 involved a purchase of 4,000 shares valued at $4.6K.
No significant insider buying has been recorded for INNT in the recent period.
No significant insider selling has been recorded for INNT in the recent period.
Based on recent SEC filings, insider sentiment for INNT is bullish with an Insider Alignment Score of 100/100 and a net flow of $624.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at INNOVATE BIOPHARMACEUTICALS, INC. (INNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INNT stock, having executed 43 transactions in the past 90 days. The most active insider is David H. Clarke (Executive), who has made 11 transactions totaling $542.3K.
Get notified when executives and directors at INNT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 28, 2019 | Laumas Sandeep | Executive | Purchase | 4,000 | $1.15 | $4.6K | |
| Jun 13, 2019 | Laumas Sandeep | Executive | Purchase | 591 | $1.22 | $721 | |
| Jun 13, 2019 | Laumas Sandeep | Executive | Purchase | 409 | $1.21 | $495 | |
| May 30, 2019 | P. Madan Jay | Executive | Purchase | 5,000 | $1.32 | $6.6K | |
| May 24, 2019 | Proujansky Roy | Executive | Purchase | 1,000 | $1.28 | $1.3K | |
| May 22, 2019 | Laumas Sandeep | Executive | Purchase | 5,000 | $1.38 | $6.9K | |
| Nov 30, 2018 | Laumas Sandeep | Executive | Purchase | 1,000 | $2.62 | $2.6K | |
| Nov 30, 2018 | Laumas Sandeep | Executive | Purchase | 1,000 | $2.63 | $2.6K | |
| Nov 30, 2018 | Laumas Sandeep | Executive | Purchase | 1,000 | $2.64 | $2.6K | |
| Nov 30, 2018 | Proujansky Roy | Executive | Purchase | 1,400 | $2.63 | $3.7K | |
| Nov 29, 2018 | Laumas Sandeep | Executive | Purchase | 2,000 | $2.56 | $5.1K | |
| Nov 29, 2018 | Laumas Sandeep | Executive | Purchase | 1,000 | $2.55 | $2.5K | |
| Nov 29, 2018 | P. Prior Christopher | Executive | Purchase | 5,000 | $2.75 | $13.8K | |
| Sep 14, 2018 | P. Prior Christopher | Executive | Purchase | 200 | $5.82 | $1.2K | |
| Sep 12, 2018 | P. Prior Christopher | Executive | Purchase | 500 | $6.13 | $3.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 35 | $624.2K | 100.0% |
Award(A) | 8 | $0 | 0.0% |
Insiders at INNOVATE BIOPHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 8 insiders making 43 transactions totaling $624.2K in purchases versus $0 in sales, the net buying activity of $624.2K signals strong executive confidence. David H. Clarke (Executive) leads the buying activity with $542.3K in transactions across all time.